Chinese veterinary drug company Skystar Bio-Pharmaceutical announced
Monday that its new GMP certified production facilities have been completed and
are fully operational.
According to the company, its new facilities meet or
exceed all Good Manufacturing Practice (GMP) Certification Standards and have
received GMP Certification from the Chinese government. The new facilities cover
an area of over 7.74 acres and will be able to produce 6,250 tons of
microecologics /probiotics feed additives, 50 million doses of medicines in
liquid form, 200 million tablets and 3,000 metric tons of powder and other forms
of veterinary medicines.
New standard in China
certification is a new pharmaceutical manufacturing standard in which all
pharmaceutical companies must be in compliance with to be able to sell their
products in China. According to the company, the increased demand for its
products in recent years has been partially due to many competing firms being
forced out of the industry due to these more stringent
Skystar's product line
consists of more than 60 existing products with over 50 in the developmental
stage, including what the company claims is a new feed additive and vaccine for
To comment, login here
Or register to be able to comment.